Showing results (31-40 of 715) with videos related to
Sort By:
Pageof 72
Expert Review of Anti-Infective Therapy|October 20, 2018
Managing HCV treatment failure and the potential of resistance testing in informing second-line therapy optionsElisabetta Loggi, Ranka Vukotic, Pietro AndreoneJournal of Viral Hepatitis|December 8, 2016
NS5A inhibitors for the treatment of hepatitis C infectionStefano Gitto, Nesrine Gamal, Pietro AndreoneDigestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 9, 2014
Prospective, observational real-life study on eligibility for and outcomes of antiviral treatment with peginterferon α plus ribavirin in chronic hepatitis CRanka Vukotic, Nesrine Gamal, Pietro AndreoneJournal of Hepatology|June 29, 2016
Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antiviralsFabio Conti, Federica Buonfiglioli, Alessandra Scuteri, et al.European Radiology|September 13, 2017
Imaging features of microvascular invasion in hepatocellular carcinoma developed after direct-acting antiviral therapy in HCV-related cirrhosisMatteo Renzulli, Federica Buonfiglioli, Fabio Conti, et al.Plos One|November 11, 2017
Monitoring the treatment of hepatitis C with directly acting antivirals by serological and molecular methodsElisabetta Loggi, Silvia Galli, Giovanni Vitale, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 3, 2019
Transjugular Intrahepatic Portosystemic Shunt does not affect the efficacy and safety of direct-acting antivirals in patients with advanced cirrhosis: A real-life, case-control studyStefano Gitto, Francesco Vizzutti, Filippo Schepis, et al.Clinical Transplantation|February 13, 2009
Two yr mycophenolate mofetil plus low-dose calcineurin inhibitor for renal dysfunction after liver transplantMaurizio Biselli, Giovanni Vitale, Annagiulia Gramenzi, et al.Journal of Hepatology|January 23, 2009
Anti-HBs re-seroconversion after liver transplantation in a patient with past HBV infection receiving a HBsAg positive graftElisabetta Loggi, Florian Bihl, John V Chisholm, et al.Internal and Emergency Medicine|September 26, 2020
Liver transplantation in Italy in the era of COVID 19: reorganizing critical care of recipientsAntonio Siniscalchi, Giovanni Vitale, Maria Cristina Morelli, et al.Pageof 72